MassChallenge is a zero-equity, zero-fee accelerator funded by corporate and public partnerships. Its US early-stage program gives founders world-class mentoring, curriculum, and corporate connections, with top performers competing for non-dilutive cash prizes. It is industry-agnostic and open globally.
- Location:
- Remote
- Duration:
- 16 weeks
Why this could be a strong fit
Perfect for early-stage, capital-conscious founders who want serious mentorship, corporate access, and a shot at non-dilutive cash without giving up equity.
What you need to qualify
- Under $3M in trailing 12-month revenue.
- Less than $5M in equity funding.
- For pre-seed, seed and pre-revenue ventures, traction is judged on customer interviews and feedback, revenue generation or pre-orders, website traffic and engagement, letters of intent or proofs of concept, technology readiness levels, and preclinical progress for life sciences and biotech.
- Participants are expected to engage with at least five of their 1:1 industry-matched mentors during the program.
Eligibility
- Eligible stages
- All stages
- Countries
- Global, subject to the provider’s eligibility and approval
How to apply
- 1
Check the size limits
The U.S. Early Stage Program is built for startups with under $3M in trailing 12-month revenue and less than $5M in equity funding.
- 2
Find the track that is open
The U.S. Early Stage Program runs as separate industry tracks (Healthcare, Climate, Security & Resiliency and Finance), each with its own window and length. When nothing is open the programs page says "Please check back for upcoming programming."
- 3
Register on the application platform
Applications are submitted at accelerate.masschallenge.org. The Apply button sends you to the login page with a register step, so you create an account before you can start the form.
- 4
Get on the notification list if nothing is open
MassChallenge asks founders to fill in an interest form to be notified when new programs are announced, and lists programs@masschallenge.org for program questions.